WO2025262247 - TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO
National phase entry is expected:
Publication Number
WO/2025/262247
Publication Date
26.12.2025
International Application No.
PCT/EP2025/067329
International Filing Date
20.06.2025
Title **
[English]
TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO
[French]
TRAITEMENT DE TROUBLES DE CÉPHALÉE ET/OU DE SYMPTÔMES PSYCHIATRIQUES À L'AIDE D'ANTICORPS ANTI-CGRP, ET COMPOSITIONS ET PROCÉDÉS ASSOCIÉS
Applicants **
H. LUNDBECK A/S
Inventors
EBERT, Bjarke
ETTRUP, Anders, Janusz
LEE, Xin, Ying
AWAD, Susanne
BOSERUP, Line, Pickering
Priority Data
63/662,745
21.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3119 | |
| EPO | Filing, Examination, Granting | 16459 | |
| Japan | Filing, Examination, Granting | 2480 | |
| South Korea | Filing, Examination, Granting | 2668 | |
| USA | Filing, Examination, Granting | 6190 |
Total:
30,916
Contact Us
Abstract[English]
Methods for treating or preventing migraine and/or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a migraine patient having one or more psychiatric symptoms such as depressive symptoms and/or suffering from a psychiatric disorder such as depression. Methods of treating or preventing one or more psychiatric symptoms such as depressive symptoms or a psychiatric disorder such as depression are also provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof. Pharmaceutical compositions related to such methods are also provided.[French]
L'invention concerne des méthodes de traitement ou de prévention de la migraine et/ou de la céphalée, consistant à administrer un anticorps antagoniste anti-CGRP à un patient migraineux présentant un ou plusieurs symptômes psychiatriques tels que des symptômes dépressifs, et/ou souffrant d'un trouble psychiatrique tel que la dépression. L'invention concerne également des méthodes de traitement ou de prévention d'un ou de plusieurs symptômes psychiatriques tels que des symptômes dépressifs, ou d'un trouble psychiatrique tel que la dépression, consistant à administrer un anticorps antagoniste anti-CGRP à un patient en ayant besoin. L'invention concerne également des compositions pharmaceutiques associées à de telles méthodes.